SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-039188
Filing Date
2019-10-31
Accepted
2019-10-31 16:54:27
Documents
51
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnlo-10q_20190930.htm 10-Q 2491051
2 EX-31.1 mnlo-ex311_8.htm EX-31.1 17394
3 EX-31.2 mnlo-ex312_6.htm EX-31.2 18428
4 EX-32.1 mnlo-ex321_7.htm EX-32.1 14016
  Complete submission text file 0001564590-19-039188.txt   7034348

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mnlo-20190930.xml EX-101.INS 1508689
6 XBRL TAXONOMY EXTENSION SCHEMA mnlo-20190930.xsd EX-101.SCH 35389
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnlo-20190930_cal.xml EX-101.CAL 42228
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnlo-20190930_def.xml EX-101.DEF 106351
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnlo-20190930_lab.xml EX-101.LAB 319980
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnlo-20190930_pre.xml EX-101.PRE 227562
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 191184303
SIC: 2834 Pharmaceutical Preparations